Cover Image
市場調查報告書

印度生物性骨材市場預測

India Orthobiologics Market Outlook to 2021

出版商 GlobalData 商品編碼 297069
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Back to Top
印度生物性骨材市場預測 India Orthobiologics Market Outlook to 2021
出版日期: 2015年09月11日 內容資訊: 英文 58 Pages
簡介

本報告提供印度生物性骨材市場相關的人工骨替代材料,關節內補充劑,自體骨移植片,骨生長刺激植入裝置等各類別銷售額,彙整銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再加上主要企業簡介,開發中產品,主要的財務相關交易的最新資訊等等,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 生物性骨材市場區分
  • 該報告針對的市場定義

第3章 印度生物性骨材市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • DePuy Companies
  • Sanofi
  • Baxter International Inc.
  • Medtronic, Inc.
  • Orthofix International N.V.
  • Biomet, Inc.
  • Smith. Nephew Plc
  • Wright Medical Group, Inc.
  • Stryker Corporation

第5章 開發中產品

第6章 財務交易情勢

  • 資本交易
  • 聯盟

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC1133DB

GlobalData's new report, "India Orthobiologics Market Outlook to 2021", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the India Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, India

  • 3.1. Orthobiologics Market, India, Revenue ($m), 2007-2014
  • 3.2. Orthobiologics Market, India, Revenue ($m), 2014-2021
    • 3.2.1. Bone Grafts and Substitutes Market, India, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Viscosupplementation Market, India, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Bone Grafts and Substitutes Market, India, Revenue ($m), by Segment, 2014-2021
    • 3.2.4. Bone Growth Stimulators Market, India, Revenue ($m), by Segment, 2014-2021
    • 3.2.5. Viscosupplementation Market, India, Revenue ($m), by Segment, 2014-2021
  • 3.3. Orthobiologics Market, India, Volume (Units), 2007-2014
  • 3.4. Orthobiologics Market, India, Volume (Units), 2014-2021
    • 3.4.1. Bone Grafts and Substitutes Market, India, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Viscosupplementation Market, India, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Bone Grafts and Substitutes Market, India, Volume (Units), by Segment, 2014-2021
    • 3.4.4. Bone Growth Stimulators Market, India, Volume (Units), by Segment, 2014-2021
    • 3.4.5. Viscosupplementation Market, India, Volume (Units), by Segment, 2014-2021
  • 3.5. Orthobiologics Market, India, Average Price ($), 2007-2021
  • 3.6. Orthobiologics Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Orthobiologics Market, India, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in India, Orthobiologics Market

  • 4.1. DePuy Companies
    • 4.1.1. Company Overview
  • 4.2. Medtronic plc
    • 4.2.1. Company Overview
  • 4.3. Bioventus LLC
    • 4.3.1. Company Overview
  • 4.4. Arthrex, Inc.
    • 4.4.1. Company Overview
  • 4.5. Eucare Pharmaceuticals (P) Ltd.
    • 4.5.1. Company Overview
  • 4.6. Baxter International Inc.
    • 4.6.1. Company Overview
  • 4.7. Sanofi
    • 4.7.1. Company Overview
  • 4.8. Seikagaku Corporation
    • 4.8.1. Company Overview
  • 4.9. Fidia farmaceutici S.p.A.
    • 4.9.1. Company Overview
  • 4.10. Biopore Surgicals Private Limited
    • 4.10.1. Company Overview
  • 4.11. Stryker Corporation
    • 4.11.1. Company Overview
  • 4.12. Anika Therapeutics, Inc.
    • 4.12.1. Company Overview

5. Orthobiologics Market Pipeline Products

6. Appendix

  • 6.1. Research Methodology
    • 6.1.1. Coverage
    • 6.1.2. Secondary Research
    • 6.1.3. Primary Research
    • 6.1.4. Market Modeling and Forecasting
    • 6.1.5. Company Share Analysis
    • 6.1.6. Distribution Share Analysis
  • 6.2. Expert Panel
  • 6.3. GlobalData Consulting
  • 6.4. Contact Us
  • 6.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Viscosupplementation Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: Bone Growth Stimulators Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Viscosupplementation Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Orthobiologics Market, India, Volume (Units), Historic, 2007-2014
  • Table 9: Orthobiologics Market, India, Volume (Units), Forecast, 2014-2021
  • Table 10: Bone Grafts and Substitutes Market, India, Volume (Units), Historic, 2007-2014
  • Table 11: Viscosupplementation Market, India, Volume (Units), Historic, 2007-2014
  • Table 12: Bone Grafts and Substitutes Market, India, Volume (Units), Forecast, 2014-2021
  • Table 13: Bone Growth Stimulators Market, India, Volume (Units), Forecast, 2014-2021
  • Table 14: Viscosupplementation Market, India, Volume (Units), Forecast, 2014-2021
  • Table 15: Orthobiologics Market, India, Average Price ($) Historic, 2007-2014
  • Table 16: Orthobiologics Market, India, Average Price ($), Forecast, 2014-2021
  • Table 17: Orthobiologics Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 18: Orthobiologics Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 19: Orthobiologics Market Pipeline Products
  • Table 20: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Viscosupplementation Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 6: Bone Growth Stimulators Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Viscosupplementation Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Orthobiologics Market, India, Volume (Units), Historic, 2007-2014
  • Figure 9: Orthobiologics Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 10: Bone Grafts and Substitutes Market, India, Volume (Units), Historic, 2007-2014
  • Figure 11: Viscosupplementation Market, India, Volume (Units), Historic, 2007-2014
  • Figure 12: Bone Grafts and Substitutes Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 13: Bone Growth Stimulators Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 14: Viscosupplementation Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 15: Orthobiologics Market, India, Company Share (%) 2014
  • Figure 16: GlobalData Epidemiology-Based Forecasting Model
  • Figure 17: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 18: Primary Interviews by Participant Type (%)
Back to Top